Company Filing History:
2 out of 2 
1 out of 1,745 
1 out of 42 Years Active: 2018
Title: Gaël Jalce: Innovator in Pulmonary Hypertension Treatment
Introduction: Gaël Jalce, a prominent inventor based in Saint-Michel-sur-Orge, France, has made significant contributions to the field of medical research. His work focuses on developing innovative solutions for treating pulmonary hypertension, a condition that poses serious health risks to patients.
Latest Patents: Jalce holds a patent for "MIF inhibitors for the acute or chronic treatment of pulmonary hypertension." This invention relates to the use of compounds of general Formula I and pharmaceutically acceptable enantiomers, salts, or solvates thereof, aimed at treating pulmonary hypertension in a subject. This patent showcases his commitment to improving patient outcomes through targeted therapies.
Career Highlights: Throughout his career, Gaël Jalce has been affiliated with notable institutions such as Mifcare and the Institut National de la Santé et de la Recherche Médicale (INSERM). His work in these organizations has allowed him to focus on critical research that addresses urgent health challenges.
Collaborations: Jalce has collaborated with esteemed colleagues, including Christophe Guignabert and Morane Le Hiress. These partnerships have contributed to the advancement of his research and the development of innovative treatments in the healthcare sector.
Conclusion: Gaël Jalce's innovative work and patent in the field of pulmonary hypertension reflect his dedication to advancing medical science. His collaborations and career achievements underscore the importance of teamwork in fostering new solutions that can make a significant impact on patient health. As he continues his work, his contributions are expected to drive further advancements in the treatment of pulmonary conditions.